Press release
Elbrit Life Sciences Raises $3 Million investment from Capital Investments
Elbrit Life Sciences is happy to announce that it is expanding its footprint in the domestic pharmaceutical industry. The fast-growing domestic pharmaceutical company is presently in advanced talks with its parent investment firm Capital Investments and a Qatar based investment firm to raise 3 million USD. This major investment is aimed at expanding the company’s domestic footprint in branded formulation business. Elbrit Life Sciences started its operations in 2014 and has since witnessed an impressive growth rate of more than 100% per annum.“We are planning to use the additional funds to expand the geographical footprint and to focus on nephrology, urology, gynaecology and oncology therapy segments”, said the spokesperson of Elbrit Life Sciences, while talking about the expansion plans. He added that the company majorly operates in South India and has sales force strength of 200 frontline sales representatives. It has 45 brands and 150 SKUs. He further added that “The company is currently not looking at any acquisitions and instead prefers to take the organic route to fuel further growth”.
In addition, Elbrit Life Sciences is aggressively focusing on cardiovascular, diabetes, neurology and nutraceuticals market in the country. Operating in a country with a population exceeding 1.3 billion, Elbrit Life Sciences has a dedicated WHO-GMP manufacturing facility. Moreover, the pharma company is in the process of upgrading its facilities to foray into export markets.
The company is expecting that this deal may close before the 2ndweek of October and once the deal is closed, the company expects to pursue growth opportunities. Furthermore, Elbrit Life Sciences also aims to be amongst the Top 150 pharmaceutical companies by the year 2020. According to the company spokesperson, Elbrit Life Sciences plans to go for an IPO somewhere around the year 2022.
About Elbrit Life Sciences:
Elbrit Life Sciences is a pharmaceutical company established with a vision of “Making Lives Better” by providing quality healthcare to patients. Established in 2014, with headquarters in Mumbai, we aspire to be one of the leading pharmaceutical companies in the country and across the globe.
For more information, please visit www.elbrit.org
Media Contact:
Contact: Mr. Prateek Sharma (9868016132)
Company Name: Elbrit Life Science Private Limited
Email: support@elbrit.org
URL: www.elbrit.org
Phone: 022-67869436
Address: Elbrit Life Sciences Private Limited,
Level 4, A Wing, Dynasty Business Park,
Andheri Kurla Road, Andheri ( E ),
Mumbai-400059
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Elbrit Life Sciences Raises $3 Million investment from Capital Investments here
News-ID: 1282213 • Views: …
More Releases for Science
Guangming Science City: Science Empowers Industry, Innovation Wins the Future
On December 5, the Guangming Science City Forum 2024 kicked off at Guangming Cloud Valley International Convention Center, bringing together cutting-edge intellectual resources at home and abroad and top minds in science and technology, education, and industry. Themed "Fusion", "Collaboration", and "Endeavour", it was hosted by Shenzhen Municipal People's Government, featuring a plenary session, as well as several thematic parallel forums held in venues at Guangming Science City and Hong…
Carlo Artemi Releases New Book - A Passage Called Science: What's Science?
Renowned Italian author and physicist, Carlo Artemi, is proud to announce the release of his latest book, A Passage Called Science: What's Science? This enlightening work is set to transform the way we perceive and understand the world of science.
In a world where the term "science" is used ubiquitously, Carlo Artemi delves deep into its essence, unraveling its mysteries and answering fundamental questions. "What is science?" "Who is the scientist?"…
Jeremy McGilvrey Announces "Science Fiction Is Now Science Fact
Houston-Based CRO Agency Jeremy McGilvrey Announces "Science Fiction Is Now Science Fact"
Jeremy McGilvrey, a Houston-based digital marketing agency announces that what was once thought to be science fiction when it comes to AI in lead generation, marketing and digital presence has become science fact.
Jeremy McGilvrey agency believes the future isn't coming, it's here. Specifically, the digital marketing agency argues that advancements in AI and data science under the context of…
ORU Offers New Master’s Degrees in Computer Science and Data Science
Tulsa, OK – Oral Roberts University’s Department of Computing & Mathematics has introduced new master’s degrees in MSCS – Computer Science and MSCS – Data Science. Available to students on campus, the Master of Science in Computer Science (MSCS) has two concentrations to choose from – Computer Science and Data Science.
According to code.org, there are more than 389,000 computing jobs open nationwide, and less than 72,000 computer sciences students graduated…
SeeRRI meets Junge Uni Krems: science literacy and science education (SLSE)
The SLSE indicator in the MORRI framework (Strand, 2015) reflects the importance of societal aspects of science in science curricula for 15 to 18-year-old students. In order to create some impact on this indicator, the SeeRRI project is organizing educational activities related to entrepreneurship and the societal aspects of science and innovation in three territories.
The Research and Innovation Management GmbH and the University of Haifa prepared a first workshop…
Bioelectronic Medicine: Science Fiction or Science Fact?
The resounding answer to the above question is, science fact! Bioelectronic Medicine is, and will continue to be, one of the fastest-growing industries, within the medical sector. BAC Medical Marketing has positioned itself perfectly to take full advantage of the rapid growth of Bioelectronic Medicine by offering a state-of-the-art device, and accompanying software, that has been used successfully by doctors on their patients throughout Europe and Asia for many years,…